99% Savings - Buy Just @1 Rs X
Mabtas N is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. The alternative uses of Mabtas N have also been explained below.
The optimal dosage of Mabtas N is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Mabtas N include Weakness. While these are the most often observed Mabtas N side effects, there are can be others also. These have been listed below. These side effects of Mabtas N are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Mabtas N has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Mabtas N related warnings talks about Mabtas N's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Mabtas N since this can cause severe adverse effects. Other contraindications of Mabtas N have been discussed in the sections ahead.
Besides this, Mabtas N may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Mabtas N is considered not safe while driving, and is not addictive.
Mabtas N is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas N safe for pregnant women?
Mabtas N may have some side effects during pregnancy. Pregnant women should discontinue the use of Mabtas N, and talk to their doctor, if they notice any discomfort.
Is the use of Mabtas N safe during breastfeeding?
Mabtas N may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Mabtas N on the Kidneys?
Mabtas N can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Mabtas N on the Liver?
Mabtas N does not damage the liver.
What is the effect of Mabtas N on the Heart?
Mabtas N can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Mabtas N should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mabtas N unless your doctor advises you to do so -
Is this Mabtas N habit forming or addictive?
Mabtas N is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Mabtas N, you should not drive or work on any heavy machine, as Mabtas N can make you drowsy.
Is it safe?
Yes, but consume Mabtas N only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Mabtas N for mental disorders.
Interaction between Food and Mabtas N
It is safe to take Mabtas N with food.
Interaction between Alcohol and Mabtas N
No research has been done on this till date. Therefore, it is not known what the effect of taking Mabtas N with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872